http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-115109031-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_da2ec7e503bd56fc78eb57ae780b64ac
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07B2200-13
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P15-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P15-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P17-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P17-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P17-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D401-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D233-86
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4439
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P5-28
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P15-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P17-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P17-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P17-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D401-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4439
filingDate 2021-03-23-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_30016a52794a5c91999cd332d03e70ca
publicationDate 2022-09-27-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber CN-115109031-A
titleOfInvention Anhydrous polymorphs of androgen receptor antagonists and their preparation and use
abstract The invention belongs to the technical field of pharmaceutical crystal chemistry, and particularly relates to an anhydrous polymorph of an androgen receptor antagonist and a preparation method and application thereof. Specifically, the present invention provides four anhydrous polymorphs of the compound of formula I (with crystal forms A, B, C and D, respectively), methods for preparing each of these anhydrous polymorphs, including these anhydrous polymorphs Pharmaceutical compositions of polymorphs, and uses in the prevention, alleviation and/or treatment of diseases or conditions associated with androgen receptor activity.
priorityDate 2021-03-23-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID450805708
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID450487057
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID11251
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID450423205
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID448417088
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID18430475
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID22018518
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID21899848
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID22180045
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID18406121
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID22263336
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID21907733
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID448765477
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID21864698
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID21875152
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID21585056
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID449661807
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID453625527
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID450151987
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID453851270
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID451878892
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID425064323

Total number of triples: 49.